Package Leaflet: Information for the User
ZARATOR 20mg chewable tablets
atorvastatina
Read this leaflet carefully before you start taking this medicine,because it contains important information for you.
1.What is Zarator and what it is used for
2.What you need to know before taking Zarator
3.How to take Zarator
4.Possible side effects
5.Storage of Zarator
6.Contents of the pack and additional information
Zarator belongs to a group of medications known as statins, which are medications that regulate lipids (fats).
Zarator is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes alone have failed.If you have a high risk of heart disease,Zaratormay also be used to reduce this risk even if your cholesterol levels are normal.During treatment, a standard low-cholesterol diet must be followed.
Do not take Zarator
Warnings and precautions
Consult your doctor, pharmacist or nurse before starting to take Zarator.
In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment with Zarator to predict the risk of adverse effects related to muscle. It is known that the risk of adverse effects related to muscle (e.g. rhabdomyolysis) increases when certain medicines are taken at the same time (see section 2 “Use of Zarator with other medicines”).
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and additional medicines may be necessary to diagnose and treat this problem.
While taking this medicine, your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in your blood, overweight and high blood pressure.
Other medicines and Zarator
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine. There are some medicines that can affect the proper functioning of Zarator or the effects of these medicines may be modified by Zarator. This type of interaction may reduce the effect of one or both medicines. Alternatively, this combined use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in section 4:
Taking Zarator with food, drinks and alcohol
See section 3 for instructions on how to take Zarator. Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day because large amounts of orange juice can alter the effects of Zarator.
Alcohol
Avoid drinking large amounts of alcohol while taking this medicine. See the details in section 2 “Warnings and precautions”
Pregnancy, breastfeeding and fertility
Do not take Zarator if you are pregnant, think you may be pregnant or intend to become pregnant.
Do not take Zarator if you are fertile unless you take adequate contraceptive measures.
Do not take Zarator if you are breastfeeding your child.
Zarator has not been shown to be safe during pregnancy and breastfeeding.
Consult your doctor or pharmacist before using any medicine.
Driving and operating machinery
This medicine usually does not affect your ability to drive or operate machinery. However, do not drive if this medicine affects your ability to drive. Do not operate tools or machinery if this medicine affects your ability to handle them.
Zarator contains aspartame
This medicine contains 2.5 mg of aspartame in each chewable tablet.
Aspartame contains a source of phenylalanine that may be harmful in the case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it correctly.
Zarator contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per chewable tablet, which is essentially “sodium-free”.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with Zarator.
The usual initial dose of Zarator is 10 mg once a day in adults and children aged 10 years and older. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of Zarator is 80 mg once a day.
Zarator tablets can be chewed or swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.
Follow exactly the administration instructions for this medication indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Your doctor will decide the duration of treatment with Zarator
Ask your doctor if you think the effect of Zarator is too strong or too weak.
If you take more Zarator than you should
If you accidentally take too many chewable tablets of Zarator (more than your usual daily dose), consult your doctor or the nearest hospital or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken. Bring the remaining tablets, the packaging, and the complete box so that the hospital staff can easily identify the medication you have taken.
If you forget to take Zarator
If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Zarator
If you have any other questions about the use of this medication or want to interrupt treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following side effects or severe symptoms, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency department.
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Other possible side effects with Zarator
Frequent: may affect up to 1 in 10 people
Infrequent: may affect up to 1 in 100 people
Rare:may affect up to 1 in 1,000 people
Very rare:may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from available data:
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Possible side effects of some statins (medicines of the same type):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keepthis medicationout of sight and reachof children.
Do not usethis medicationafter the expiration datethat appears on the blister and on the packaging after “CAD”. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. Ask your pharmacist how to dispose of packaging and medications you no longer need.This will help protect the environment.
Each tablet contains 20 mg of atorvastatina (as atorvastatina calcium trihydrate).
Appearance of the product and contents of the packaging
Zarator 20 mg chewable tablets are white or off-white, with pink to purple speckling, round in shape. They are marked with 20 on one side and LCT on the other.
Zarator 20 mg chewable tablets are presented in packaging with blisters containing 30 chewable tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible for manufacturing
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg Im Breisgau
Germany
You can request more information about this medication by contacting the local representative of the holder of the marketing authorization:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 Madrid
Spain
Last review date of this leaflet: October 2024
The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.